Johnson & Johnson (J&J) has agreed to a $5.5 billion settlement to resolve tens of thousands of U.S. lawsuits alleging its talc-based baby powder caused ovarian cancer. The agreement, announced July 28, 2026, becomes final only if 95 percent of claimants in state and federal courts accept the terms. While this settles the U.S. litigation, the company still faces a product liability case in the United Kingdom.
The $5.5 Billion U.S. Talc Settlement Terms
J&J’s decision to pay $5.5 billion aims to end a decade of legal battles. Erik Haas, J&J’s litigation head, stated the agreement allows the company to “put this matter behind it.” Lawyers for the plaintiffs described the deal as a good resolution to the long-running conflict.
The company continues to deny that talc causes cancer. Despite this stance, J&J stopped selling talc-based baby powder in the U.S. in 2020 and ceased worldwide sales in 2023. The move follows a pattern of juries across the U.S. awarding plaintiffs damages, even after some earlier cases were overturned.
Did you know? The World Health Organization classified talc as “probably carcinogenic to humans” in 2024, adding scientific weight to the claims seen in these court cases.
UK High Court Faces Liability Case
The U.S. settlement does not extend to the United Kingdom. A separate legal action, filed in October 2025, is currently being adjudicated in the UK High Court. This represents the largest product liability case in UK history, involving more than 7,000 potential claimants.
The UK claimants allege that J&J was aware that its talc could cause mesothelioma and ovarian cancers but continued to market the product. J&J denies these allegations.
Comparison of U.S. vs. UK Legal Stakes
| Feature | United States | United Kingdom |
|---|---|---|
| Status | $5.5bn Settlement agreed | Ongoing adjudication |
| Claimant Volume | Tens of thousands | 7,000+ potential claimants |
| Primary Allegations | Ovarian cancer | Ovarian cancer & Mesothelioma |
Industry Shift Toward Talc-Free Alternatives
Frequently Asked Questions
Does the $5.5 billion settlement cover everyone?
No. It covers tens of thousands of U.S. claimants, but it requires 95 percent acceptance to be final. It does not cover claimants in the United Kingdom.
Why did J&J stop selling talc powder if they deny it causes cancer?
The company stopped U.S. sales in 2020 and worldwide sales in 2023, though they maintain there is no evidence linking the product to cancer.
What is the status of the UK case?
The case, filed in October 2025 involving over 7,000 people, is currently before the UK High Court.
Stay Updated on Global Product Liability
Want more insights into the legal battles shaping consumer safety? Subscribe to our newsletter or leave a comment below with your thoughts on the UK High Court proceedings.
Worth a look